Trexquant Investment LP

Position in VERA — Vera Therapeutics, Inc.

CIK 1633445 STAMFORD, CT

Position in VERA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,487,337

+$952,552 QoQ

Shares Held

86,685

+73.2% QoQ

Ownership

0.121%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

9 quarters on record

Voting authority Sole 91.03651150718117.ToString("F0")% Shared 0.ToString("F0")% None 8.963488492818827.ToString("F0")%

Healthcare · as of Mar 31, 2026

Trexquant Investment LP holds $494,710,504 across 119 Biotechnology names. VERA ranks #51 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	483,971	$24,585,726
2	ALNY	Alnylam Pharmaceuticals, Inc.	61,760	$20,434,531
3	ARWR	Arrowhead Pharmaceuticals, Inc.	277,114	$17,375,047
4	EXEL	Exelixis, Inc.	390,818	$16,762,184
5	HRMY	Harmony Biosciences Holdings, Inc.	594,850	$16,661,748
6	IONS	Ionis Pharmaceuticals Inc	213,645	$16,042,603
7	CNTA	Centessa Pharmaceuticals plc	390,951	$15,528,573
8	ASND	Ascendis Pharma A/S	65,517	$14,985,703

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,487,337	86,685	+73.2%	Shares	Sole	2026-05-15
2025-12-31	$2,534,785	50,055	-76.0%	Shares	Sole	2026-02-17
2025-09-30	$6,059,010	208,500	+36.3%	Shares	Sole	2025-11-14
2025-06-30	$3,603,714	152,959	+143.7%	Shares	Sole	2025-08-12
2025-03-31	$1,507,903	62,777	+187.1%	Shares	Sole	2025-05-14
2024-12-31	$924,628	21,864	-57.8%	Shares	Sole	2025-02-12
2024-09-30	$2,291,283	51,839	+347.9%	Shares	Sole	2024-11-12
2024-03-31	$499,114	11,575	-78.4%	Shares	Sole	2024-05-14
2023-06-30	$858,257	53,474	—	Shares	Sole	2023-08-11
No filing history on record for this holder in this stock.